Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

JOHNSON & JOHNSON : Ex-dividend day for

11/23/2020 EST

A dividend is removed today from Johnson & Johnson's share.



© Factset 2020
All news about JOHNSON & JOHNSON
01:46pJohnson & Johnson's Profit Is Boosted by Pharmaceuticals Business -- 2nd Upda..
DJ
12:40pJ&J 4Q sales rise despite pandemic, but charges cut profits
AQ
12:38pMIDDAY REPORT : US Stocks Mixed as Investors Digest Large-Cap Earnings
MT
11:41aJOHNSON & JOHNSON : Should you invest in Johnson & Johnson, Microsoft, Facebook,..
PR
11:13aMEIRAGTX : AAV-CNGA3 Gets FDA Fast-Track Designation in Achromatopsia
DJ
10:36aJOHNSON & JOHNSON : Issues Upbeat Guidance as Fourth Quarter Tops Views; COVID-1..
MT
09:45aGENMAB A/S : Reports Darzalex Sales of $4.19 Billion in 2020
MT
09:28aWall Street Wavers Pre-Bell Amid Earnings Deluge
MT
09:22aSECTOR UPDATE : Health Care Stocks Gain Pre-Bell Tuesday
MT
09:03aJohnson & Johnson's Profit Is Boosted by Pharmaceuticals Business --Update
DJ
More news
Financials (USD)
Sales 2020 81 721 M - -
Net income 2020 15 924 M - -
Net Debt 2020 5 967 M - -
P/E ratio 2020 27,2x
Yield 2020 2,39%
Capitalization 437 B 437 B -
EV / Sales 2020 5,42x
EV / Sales 2021 4,81x
Nbr of Employees 132 200
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | MarketScreener
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 166,31 $
Last Close Price 165,98 $
Spread / Highest target 9,05%
Spread / Average Target 0,20%
Spread / Lowest Target -16,3%
EPS Revisions
Managers and Directors
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON5.46%436 949
ROCHE HOLDING AG3.82%309 894
NOVARTIS AG2.96%220 401
PFIZER INC.1.28%207 217
MERCK & CO., INC.-0.79%205 312
ABBVIE INC.3.13%195 085